<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Innovation Pharmaceuticals Inc — News on 6ix</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc</link>
<description>Latest news and press releases for Innovation Pharmaceuticals Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 17 Apr 2023 12:01:40 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/innovation-pharmaceuticals-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835849478dffbe2df0fd2a0.webp</url>
<title>Innovation Pharmaceuticals Inc</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc</link>
</image>
<item>
<title>Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-brilacidin-antifungal-research-published-in-nature-communications</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-brilacidin-antifungal-research-published-in-nature-communications</guid>
<pubDate>Mon, 17 Apr 2023 12:01:40 GMT</pubDate>
<description>Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-new-antifungal-testing-of-brilacidin-by-nihniaid-affiliated-and-other-academic-researchers</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-new-antifungal-testing-of-brilacidin-by-nihniaid-affiliated-and-other-academic-researchers</guid>
<pubDate>Wed, 15 Mar 2023 12:00:46 GMT</pubDate>
<description>Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-visits-beamed-new-stingray-laser-system-for-epilepsy-and-brain-tumors-moving-toward-fda-submission</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-visits-beamed-new-stingray-laser-system-for-epilepsy-and-brain-tumors-moving-toward-fda-submission</guid>
<pubDate>Thu, 23 Feb 2023 13:03:40 GMT</pubDate>
<description>Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-bt-beamedical-technologies-and-shina-systems-ltd-enter-into-a-definitive-strategic-development-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-bt-beamedical-technologies-and-shina-systems-ltd-enter-into-a-definitive-strategic-development-agreement</guid>
<pubDate>Mon, 09 Jan 2023 12:31:31 GMT</pubDate>
<description>Innovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin’s Potential for Treating Fungal Keratitis</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-reports-new-in-vivo-antifungal-data-showing-brilacidins-potential-for-treating-fungal-keratitis</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-reports-new-in-vivo-antifungal-data-showing-brilacidins-potential-for-treating-fungal-keratitis</guid>
<pubDate>Tue, 13 Dec 2022 12:31:11 GMT</pubDate>
<description>Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin’s Potential for Treating Fungal Keratitis.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Announces BT BeaMedical Technologies Receives FDA Clearance for New Surgical Laser Family</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-bt-beamedical-technologies-receives-fda-clearance-for-new-surgical-laser-family</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-bt-beamedical-technologies-receives-fda-clearance-for-new-surgical-laser-family</guid>
<pubDate>Mon, 28 Nov 2022 14:00:55 GMT</pubDate>
<description>Innovation Pharmaceuticals Announces BT BeaMedical Technologies Receives FDA Clearance for New Surgical Laser Family.</description>
</item>
<item>
<title>NHS Medical Director for Specialised Services Calls New Laser Technology for Epilepsy "Game-Changing Breakthrough"</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/nhs-medical-director-for-specialised-services-calls-new-laser-technology-for-epilepsy-game-changing-breakthrough</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/nhs-medical-director-for-specialised-services-calls-new-laser-technology-for-epilepsy-game-changing-breakthrough</guid>
<pubDate>Wed, 26 Oct 2022 13:31:11 GMT</pubDate>
<description>NHS Medical Director for Specialised Services Calls New Laser Technology for Epilepsy "Game-Changing Breakthrough".</description>
</item>
<item>
<title>Innovation Pharmaceuticals Announces Publication of Scientific Article on the Antifungal Activity of Brilacidin</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-publication-of-scientific-article-on-the-antifungal-activity-of-brilacidin</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-publication-of-scientific-article-on-the-antifungal-activity-of-brilacidin</guid>
<pubDate>Tue, 04 Oct 2022 11:31:17 GMT</pubDate>
<description>Innovation Pharmaceuticals Announces Publication of Scientific Article on the Antifungal Activity of Brilacidin.</description>
</item>
<item>
<title>New In Vitro Data Supporting the Broad-Spectrum Antiviral Activity of Innovation Pharmaceuticals' Brilacidin Presented at 2022 Military Health System Research Symposium</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/new-in-vitro-data-supporting-the-broad-spectrum-antiviral-activity-of-innovation-pharmaceuticals-brilacidin-presented-at-2022-military-health-system-research-symposium</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/new-in-vitro-data-supporting-the-broad-spectrum-antiviral-activity-of-innovation-pharmaceuticals-brilacidin-presented-at-2022-military-health-system-research-symposium</guid>
<pubDate>Thu, 15 Sep 2022 11:34:05 GMT</pubDate>
<description>New In Vitro Data Supporting the Broad-Spectrum Antiviral Activity of Innovation Pharmaceuticals' Brilacidin Presented at 2022 Military Health System Research Symposium.</description>
</item>
<item>
<title>Innovation Pharmaceuticals' Investment in BT BeaMedical Helping Advance New Surgical Laser Platform</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-investment-in-bt-beamedical-helping-advance-new-surgical-laser-platform</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-investment-in-bt-beamedical-helping-advance-new-surgical-laser-platform</guid>
<pubDate>Tue, 13 Sep 2022 11:31:21 GMT</pubDate>
<description>Innovation Pharmaceuticals' Investment in BT BeaMedical Helping Advance New Surgical Laser Platform.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Announces NIH/NIAID-Affiliated Researchers to Evaluate Brilacidin's Treatment Potential Against Monkeypox</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-nihniaid-affiliated-researchers-to-evaluate-brilacidins-treatment-potential-against-monkeypox</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-nihniaid-affiliated-researchers-to-evaluate-brilacidins-treatment-potential-against-monkeypox</guid>
<pubDate>Fri, 05 Aug 2022 13:30:27 GMT</pubDate>
<description>Innovation Pharmaceuticals Announces NIH/NIAID-Affiliated Researchers to Evaluate Brilacidin's Treatment Potential Against Monkeypox.</description>
</item>
<item>
<title>Provider and Payer Analysis Supports Potential Commercialization of Innovation Pharmaceutical's Brilacidin as a Novel Oral Mucositis Drug Candidate</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/provider-and-payer-analysis-supports-potential-commercialization-of-innovation-pharmaceuticals-brilacidin-as-a-novel-oral-mucositis-drug-candidate</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/provider-and-payer-analysis-supports-potential-commercialization-of-innovation-pharmaceuticals-brilacidin-as-a-novel-oral-mucositis-drug-candidate</guid>
<pubDate>Fri, 22 Jul 2022 11:30:31 GMT</pubDate>
<description>Provider and Payer Analysis Supports Potential Commercialization of Innovation Pharmaceutical's Brilacidin as a Novel Oral Mucositis Drug Candidate.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Announces New Antiviral Research on Brilacidin in Bunyaviruses and Alphaviruses to be Presented at the 2022 Military Health System Research Symposium</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-new-antiviral-research-on-brilacidin-in-bunyaviruses-and-alphaviruses-to-be-presented-at-the-2022-military-health-system-research-symposium</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-new-antiviral-research-on-brilacidin-in-bunyaviruses-and-alphaviruses-to-be-presented-at-the-2022-military-health-system-research-symposium</guid>
<pubDate>Tue, 28 Jun 2022 11:30:45 GMT</pubDate>
<description>Innovation Pharmaceuticals Announces New Antiviral Research on Brilacidin in Bunyaviruses and Alphaviruses to be Presented at the 2022 Military Health System Research Symposium.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Reports Brilacidin Inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 Variants Based on In Vitro Testing by NIH/NIAID-Sponsored and Rutgers University Researchers</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-reports-brilacidin-inhibits-omicron-delta-gamma-and-alpha-sars-cov-2-variants-based-on-in-vitro-testing-by-nihniaid-sponsored-and-rutgers-university-researchers</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-reports-brilacidin-inhibits-omicron-delta-gamma-and-alpha-sars-cov-2-variants-based-on-in-vitro-testing-by-nihniaid-sponsored-and-rutgers-university-researchers</guid>
<pubDate>Thu, 23 Jun 2022 11:32:03 GMT</pubDate>
<description>Innovation Pharmaceuticals Reports Brilacidin Inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 Variants Based on In Vitro Testing by NIH/NIAID-Sponsored and Rutgers University Researchers.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Acquires Stake in Squalus Medical, Seeks to Reshape Cancer and Epilepsy Treatments Through a New Image Guided Laser-Based Ablation Technology</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-acquires-stake-in-squalus-medical-seeks-to-reshape-cancer-and-epilepsy-treatments-through-a-new-image-guided-laser-based-ablation-technology</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-acquires-stake-in-squalus-medical-seeks-to-reshape-cancer-and-epilepsy-treatments-through-a-new-image-guided-laser-based-ablation-technology</guid>
<pubDate>Wed, 15 Jun 2022 14:30:52 GMT</pubDate>
<description>Innovation Pharmaceuticals Acquires Stake in Squalus Medical, Seeks to Reshape Cancer and Epilepsy Treatments Through a New Image Guided Laser-Based Ablation Technology.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Announces Publication of Peer-Review Article in the Journal of Medical Virology on Anti-Coronavirus Properties of Brilacidin</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-publication-of-peer-review-article-in-the-journal-of-medical-virology-on-anti-coronavirus-properties-of-brilacidin</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-announces-publication-of-peer-review-article-in-the-journal-of-medical-virology-on-anti-coronavirus-properties-of-brilacidin</guid>
<pubDate>Tue, 15 Mar 2022 12:31:45 GMT</pubDate>
<description>Innovation Pharmaceuticals Announces Publication of Peer-Review Article in the Journal of Medical Virology on Anti-Coronavirus Properties of Brilacidin.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Reports Additional Findings Based on Review of Brilacidin Phase 2 COVID-19 Trial Results and Compassionate Use Cases</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-reports-additional-findings-based-on-review-of-brilacidin-phase-2-covid-19-trial-results-and-compassionate-use-cases</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-reports-additional-findings-based-on-review-of-brilacidin-phase-2-covid-19-trial-results-and-compassionate-use-cases</guid>
<pubDate>Mon, 07 Mar 2022 12:35:17 GMT</pubDate>
<description>Innovation Pharmaceuticals Reports Additional Findings Based on Review of Brilacidin Phase 2 COVID-19 Trial Results and Compassionate Use Cases.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Analyzing Full Dataset for Its Brilacidin COVID-19 Clinical Trial; Company Evaluating New Pipeline Opportunities for 2022</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-analyzing-full-dataset-for-its-brilacidin-covid-19-clinical-trial-company-evaluating-new-pipeline-opportunities-for-2022</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-analyzing-full-dataset-for-its-brilacidin-covid-19-clinical-trial-company-evaluating-new-pipeline-opportunities-for-2022</guid>
<pubDate>Tue, 07 Dec 2021 12:30:36 GMT</pubDate>
<description>Innovation Pharmaceuticals Analyzing Full Dataset for Its Brilacidin COVID-19 Clinical Trial; Company Evaluating New Pipeline Opportunities for 2022.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Provides Brilacidin Program Update</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-provides-brilacidin-program-update</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-provides-brilacidin-program-update</guid>
<pubDate>Thu, 18 Nov 2021 13:32:58 GMT</pubDate>
<description>Innovation Pharmaceuticals Provides Brilacidin Program Update.</description>
</item>
<item>
<title>Innovation Pharmaceuticals Conducting Full Data Analysis of Phase 2 Brilacidin COVID-19 Trial Results to Support Brilacidin's Potential Inclusion in Government-Sponsored COVID-19 Trials</title>
<link>https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-conducting-full-data-analysis-of-phase-2-brilacidin-covid-19-trial-results-to-support-brilacidins-potential-inclusion-in-government-sponsored-covid-19-trials</link>
<guid isPermaLink="true">https://6ix.com/company/innovation-pharmaceuticals-inc/news/innovation-pharmaceuticals-conducting-full-data-analysis-of-phase-2-brilacidin-covid-19-trial-results-to-support-brilacidins-potential-inclusion-in-government-sponsored-covid-19-trials</guid>
<pubDate>Fri, 12 Nov 2021 13:01:28 GMT</pubDate>
<description>Innovation Pharmaceuticals Conducting Full Data Analysis of Phase 2 Brilacidin COVID-19 Trial Results to Support Brilacidin's Potential Inclusion in Government-Sponsored COVID-19 Trials.</description>
</item>
</channel>
</rss>